<DOC>
	<DOCNO>NCT00165724</DOCNO>
	<brief_summary>Open study efficacy safety donepezil treatment 48 week</brief_summary>
	<brief_title>Alzheimer 's Disease Long-term Follow-up Study ( ALF Study )</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<criteria>Inclusion criterion Men woman age 40 90 Diagnosis dementia accord DSMIV Diagnosis probable AD define NINCDSADRDA criterion Mild moderate AD baseline , define MMSE score 10 26 Patients generally healthy ambulatory ambulatory aid Patients take acetylcholinesterase inhibitor 4 week screen Patients useful MRI result 3 month screen Exclusion If evidence TIA major infarction Epilepsy patient If evidence degenerative psychiatric disorder , serious disorder , alcoholism drug abuse If sensitive acetylcholinesterase If take concomitant medication allow</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>July 2010</verification_date>
</DOC>